Rendu Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 335

Employees

  • Stock Symbol
  • 688193

Stock Symbol

  • Share Price
  • $5.29
  • (As of Thursday Closing)

Rendu General Information

Description

Shanghai Rendu Biotechnology Co Ltd provides solutions for accurate diagnosis, effective prevention and control, as well as personalized diagnosis and treatment of pathogens in the areas of reproduction, respiration, digestion, blood, food, and environmental safety.

Contact Information

Website
www.rdbio.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • No. B, Building 15
  • No. 528, Ruiqing Road, East District, Zhangjiang Hi-Tech Park
  • Shanghai, 201201
  • China
+86 021
Primary Industry
Biotechnology
Stock Exchange
SHG
Vertical(s)
Life Sciences
Corporate Office
  • No. B, Building 15
  • No. 528, Ruiqing Road, East District, Zhangjiang Hi-Tech Park
  • Shanghai, 201201
  • China
+86 021

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rendu Stock Performance

As of 15-May-2025, Rendu’s stock price is $5.29. Its current market cap is $212M with 40M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.29 $5.27 $3.24 - $6.95 $212M 40M 364K -$0.04

Rendu Financials Summary

As of 31-Mar-2025, Rendu has a trailing 12-month revenue of $24M.

In Thousands,
USD 		TTM 31-Mar-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 104,143 99,915 143,575 152,368
Revenue 24,041 24,716 23,239 45,118
EBITDA (3,095) (612) 1,732 5,564
Net Income (1,429) (1,089) 1,167 3,464
Total Assets 135,828 136,212 148,790 157,802
Total Debt 553 580 990 1,523
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Rendu Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Rendu‘s full profile, request access.

Request a free trial

Rendu Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Rendu Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2021508250-A Automatic nucleic acid sample preparation, detection and analysis system Pending 11-Oct-2017
US-20200292565-A1 Automated nucleic acid sample preparation, detection, and analysis system Inactive 11-Oct-2017

Rendu Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rendu FAQs

  • When was Rendu founded?

    Rendu was founded in 2007.

  • Where is Rendu headquartered?

    Rendu is headquartered in Shanghai, China.

  • What is the size of Rendu?

    Rendu has 335 total employees.

  • What industry is Rendu in?

    Rendu’s primary industry is Biotechnology.

  • Is Rendu a private or public company?

    Rendu is a Public company.

  • What is Rendu’s stock symbol?

    The ticker symbol for Rendu is 688193.

  • What is the current stock price of Rendu?

    As of 15-May-2025 the stock price of Rendu is $5.29.

  • What is the current market cap of Rendu?

    The current market capitalization of Rendu is $212M.

  • What is Rendu’s current revenue?

    The trailing twelve month revenue for Rendu is $24M.

  • What is Rendu’s annual earnings per share (EPS)?

    Rendu’s EPS for 12 months was -$0.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »